Functionalized Ionic Silicones for Drug Delivery and Wound Care

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current ionic silicones lack the necessary hydrophilicity and flexibility for applications such as wound care and drug delivery, where hydrophilic active agents tend to crystallize, reducing their effectiveness, and existing polymers are brittle, leading to issues like fertilizer premature release and coating cracking.

Innovation Solution

Development of functionalized ionic silicone compositions with specific ionic groups like sulfonate, sulfate, and phosphate, which provide hydrophilicity, flexibility, and controlled release capabilities, suitable for various applications including wound care, drug delivery, and agricultural uses.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If conventional ionic silicones are used, then basic ionic functionality is provided, but hydrophilicity is insufficient and drug crystallization occurs

Engineering Contradiction:
ImprovehydrophilicityVSAvoiddrug crystallization
Core Design Contradiction:
ReliabilityVSObject-generated harmful factors

Solution Approach 1:

The patent combines multiple ionic groups (sulfonate, sulfate, phosphate) with silicone backbone to create a composite material that integrates the hydrophobic stability of silicones with the hydrophilic properties of ionic groups, preventing drug crystallization while maintaining structural integrity

Inventive Principle:
Principle #40Composite materials

Solution Approach 2:

The patent modifies the chemical parameters of silicone by introducing specific ionic groups (sulfonate, sulfate, phosphate) at controlled concentrations, transforming the material from hydrophobic to hydrophilic and preventing drug crystallization

Inventive Principle:
Principle #35Parameter changes

2Strength

If existing polymers are used for coating, then coating formation is achieved, but brittleness causes cracking and premature fertilizer release

Engineering Contradiction:
ImproveflexibilityVSAvoidcoating integrity
Core Design Contradiction:
StrengthVSReliability

Solution Approach 1:

The patent changes the mechanical parameters of the polymer by incorporating ionic groups that increase chain flexibility and elasticity, transforming brittle coatings into flexible, crack-resistant films that maintain integrity while controlling fertilizer release

Inventive Principle:
Principle #35Parameter changes

3Adaptability or versatility

If functionalized ionic silicones are developed, then hydrophilicity and flexibility are improved, but formulation complexity increases

Engineering Contradiction:
Improveapplication rangeVSAvoidformulation complexity
Core Design Contradiction:
Adaptability or versatilityVSDevice complexity

Solution Approach 1:

The patent creates a universal silicone platform with multiple ionic group options (sulfonate, sulfate, phosphate) that can serve various applications (wound care, drug delivery, agriculture) through a single base formulation, reducing overall formulation complexity despite increased versatility

Inventive Principle:
Principle #6Universality (Multi-functionality)

Data Source

PatentEP3805328B1Silicone ionomer composition
Publication Date: 2022.08.31 MOMENTIVE PERFORMANCE MATERIALS INC
  • EP3805328B1 patent drawing
  • EP3805328B1 patent drawing
  • EP3805328B1 patent drawing

AI summary

There is provided herein a functionalized ionic silicone composition comprising a silicone of the formula (I): M1a M2b M3cD1d D2e D3f T1g T2h T3i Qj (I) which contains a monovalent radical bearing ion-pairs and having the formula (II): -A-lx-"Mny+; where A is a spacing group having at least 2 spacing atoms selected from a divalent hydrocarbon or hydrocarbonoxy group, where I is an ionic group such as sulfonate-S03-, carboxylate -COO-, phosphonate -PO32- group and phosphate - OPO32-, where M is hydrogen or a cation independently selected from alkali metals, alkali earth metals, transition metals, metals, quaternary ammonium and phosphonium groups; or, zwitterions having the formula (III): -R'-NR"2+-R'"-I (III) where I is defined as above, and where the subscript a, b, c, d, e, f, g, h, i, j are zero or positive subject to the following limitations: 2≤ a+b+c+d+e+f+g+h+i+j ≤ 6000, b+e+h >0 and c+f+i >0.